ALXO
ALXO
Last
$1.25
Day
+5.9%
1y
-39.2%
5y
-98.3%
52w
-55.6%
SPY YTD
+13.3%
Sec
—
Earnings
2026-11-0626d
EMA 21
1.42
EMA 50
1.65
EMA 200
1.77
20d high
-40.4%
5y high
-98.5%
5y range
1th
Positions held
Your positionsALXO isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$1.40
Stop
$0.99
Stop distance
20.8%
Target vs last
+12.0%
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-18 · Top Premarket Decliners
2026-09-02 · ALX Oncology to Present at Upcoming Investor Conferences in September
2026-08-11 · Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?
2026-08-06 · ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Price (daily)
Full chart · RSI · MACD · patternsALXO · daily-28.9% over 14 sessions
Close EMA21 EMA50 EMA200